2010
DOI: 10.2220/biomedres.31.263
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of autophagy in the liver by lipopolysaccharide-induced systemic inflammation in a rat model of diabetes mellitus

Abstract: The dysregulated metabolism associated with diabetes mellitus (DM) impairs membrane trafficking events in the liver, including the process of autophagy, which is an essential ongoing cellular process that is highly regulated by nutrients, endocrine factors, and signaling pathways. Highmobility group box 1 (HMGB1) is a nuclear protein with a known role in systemic inflammation and the related various organ injuries. However, its relationship to autophagy is not well understood. The aim of this study was to inve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 33 publications
0
12
0
Order By: Relevance
“…Many studies support this LPS toxicity [44-48]. However, Aβ42, which induced a low grade of inflammation, inhibited the activation of the mTOR pathway and could activate autophagy.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies support this LPS toxicity [44-48]. However, Aβ42, which induced a low grade of inflammation, inhibited the activation of the mTOR pathway and could activate autophagy.…”
Section: Discussionmentioning
confidence: 99%
“…32,33 However, the functional role of autophagy in other diabetic organs remains unknown. For example, in streptozotocin-diabetic rats, autophagy appears to be increased in the liver, 34,35 but reduced in the kidney. 36,37 In the OVE26 type 1 diabetic mouse heart, autophagy is inhibited, which is associated with cardiac dysfunction.…”
Section: Introductionmentioning
confidence: 99%
“…Extensive liver autophagy results in non-selective catabolization of cytoplasmic components into amino acids and free fatty acids, which are used in gluconeogenesis and beta-oxidation (Komatsu 2012). Usually, autophagy is considered as a protective mechanism, but hyperactive autophagy has also been reported in pathological conditions such as liver inflammation in a rat model of diabetes mellitus (Hagiwara et al 2010) and as a possible cause of hepatocyte death in anorexia nervosa patients (Rautou et al 2008) suggesting that both diminished or excessive autophagy could be deleterious. It has also been reported that leptin treatment might have unfavorable consequences via an overactivated leptin system and an SOCS3 inhibitory effect might lead to insulin resistance, hepatic steatosis and liver fibrosis (Polyzos et al 2011).…”
Section: Discussionmentioning
confidence: 99%